메뉴 건너뛰기




Volumn 19, Issue 4, 2007, Pages 277-282

Relationship between methylation status of Multi-drug Resistance Protein(MRP) and multi-drug resistance in lung cancer cell lines

Author keywords

Lung cancer; Methylation; Multi drug resistance protein(MRP); Multi drug resistance(MDR)

Indexed keywords

DOXORUBICIN; ENDONUCLEASE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

EID: 37549028365     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-007-0277-0     Document Type: Article
Times cited : (2)

References (11)
  • 1
    • 0031939190 scopus 로고    scopus 로고
    • Immunohistochemical detection of DNA topoisomerase IIα, P-glycoprotein and multidrug resistance protein(MRP) in small-cell and non-small-cell lung cancer[J]
    • Kreisholt J, Sorensen M, Jensen PB, et al. Immunohistochemical detection of DNA topoisomerase IIα, P-glycoprotein and multidrug resistance protein(MRP) in small-cell and non-small-cell lung cancer[J]. Bri J cancer 1998; 77: 1469-73.
    • (1998) Bri J cancer , vol.77 , pp. 1469-1473
    • Kreisholt, J.1    Sorensen, M.2    Jensen, P.B.3
  • 2
    • 0033992896 scopus 로고    scopus 로고
    • Expression and prognostic significance of multidrug resistance associated protein (MRP) gene in non-small cell lung cancer by in situ hybridization[J]
    • Shan G, Zhong H, Zhang F. Expression and prognostic significance of multidrug resistance associated protein (MRP) gene in non-small cell lung cancer by in situ hybridization[J]. Zhong Hua Zhong Liu Za Zhi 2000; 22: 27-9
    • (2000) Zhong Hua Zhong Liu Za Zhi , vol.22 , pp. 27-29
    • Shan, G.1    Zhong, H.2    Zhang, F.3
  • 3
    • 33748967231 scopus 로고    scopus 로고
    • Global DNA hyper-methylation- associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine[J]
    • Blanca SP, Enrique PC, Lucia TC, et al. Global DNA hyper-methylation- associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine[J]. J Transl Med 2006; 4: 32.
    • (2006) J Transl Med , vol.4 , pp. 32
    • Blanca, S.P.1    Enrique, P.C.2    Lucia, T.C.3
  • 4
    • 0028106023 scopus 로고
    • Cloning and Sequence analysis of the promoter region of the of HL60 cells isolated for resistance to adriamycin[J]
    • Qichao Zhu, Melvin S. Cloning and Sequence analysis of the promoter region of the of HL60 cells isolated for resistance to adriamycin[J]. Cancer Res 1994; 54: 4488-92.
    • (1994) Cancer Res , vol.54 , pp. 4488-4492
    • Zhu, Q.1    Melvin, S.2
  • 5
    • 10044270854 scopus 로고    scopus 로고
    • Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene[J]
    • Takane H, Kobayashi D, Hirota T, et al. Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene[J]. J Pharmacol Exp Ther 2004; 311:1179-87.
    • (2004) J Pharmacol Exp Ther , vol.311 , pp. 1179-1187
    • Takane, H.1    Kobayashi, D.2    Hirota, T.3
  • 7
    • 4344633280 scopus 로고    scopus 로고
    • CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer[J]
    • Enokida H, Shiina H, Igawa M,et al. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer[J]. Cancer Res 2004; 64: 5956-62.
    • (2004) Cancer Res , vol.64 , pp. 5956-5962
    • Enokida, H.1    Shiina, H.2    Igawa, M.3
  • 8
    • 22444433425 scopus 로고    scopus 로고
    • Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer Cells[J]
    • Sharma D, Blum J, Yang X, et al.Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer Cells[J]. Mol Endocrinol 2005; 19: 1740-51.
    • (2005) Mol Endocrinol , vol.19 , pp. 1740-1751
    • Sharma, D.1    Blum, J.2    Yang, X.3
  • 9
    • 0035886471 scopus 로고    scopus 로고
    • CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma[J]
    • Nojima D, Li LC, Dharia A, et al. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma[J]. Cancer 2001; 92: 2076-83.
    • (2001) Cancer , vol.92 , pp. 2076-2083
    • Nojima, D.1    Li, L.C.2    Dharia, A.3
  • 10
    • 33747359590 scopus 로고    scopus 로고
    • Methylation mediated silencing of TMS1/ASC gene in prostate cancer[J]
    • Das PM, Ramachandran K, Vanwert J, et al. Methylation mediated silencing of TMS1/ASC gene in prostate cancer[J]. Mol Cancer 2006; 5: 28.
    • (2006) Mol Cancer , vol.5 , pp. 28
    • Das, P.M.1    Ramachandran, K.2    Vanwert, J.3
  • 11
    • 0033764141 scopus 로고    scopus 로고
    • Decitabine (5-Aza-2′-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells[J]
    • Ando T, Nishimura M, Oka Y. Decitabine (5-Aza-2′-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells[J]. Leukemia 2000; 14: 1915-20.
    • (2000) Leukemia , vol.14 , pp. 1915-1920
    • Ando, T.1    Nishimura, M.2    Oka, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.